LRIG1 is a pleiotropic androgen receptor-regulated feedback tumor suppressor in prostate cancer
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
LRIG1 is a pleiotropic androgen receptor-regulated feedback tumor suppressor in prostate cancer
Authors
Keywords
-
Journal
Nature Communications
Volume 10, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-12-02
DOI
10.1038/s41467-019-13532-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tumor-suppressive effect of LRIG1, a negative regulator of ErbB, in non-small cell lung cancer harboring mutant EGFR
- (2018) Hidejiro Torigoe et al. CARCINOGENESIS
- Lrig1 is a haploinsufficient tumor suppressor gene in malignant glioma
- (2018) Feng Mao et al. Oncogenesis
- Histone 2B-GFP Label-Retaining Prostate Luminal Cells Possess Progenitor Cell Properties and Are Intrinsically Resistant to Castration
- (2018) Dingxiao Zhang et al. Stem Cell Reports
- Expression of Lrig1, a negative regulator of EGFR, is dynamically altered during different stages of gastric carcinogenesis
- (2018) Sungsook Yu et al. AMERICAN JOURNAL OF PATHOLOGY
- Linking prostate cancer cell AR heterogeneity to distinct castration and enzalutamide responses
- (2018) Qiuhui Li et al. Nature Communications
- Lrig1 marks a population of gastric epithelial cells capable of long-term tissue maintenance and growth in vitro
- (2018) Pawel J. Schweiger et al. Scientific Reports
- Lrig1+ gastric isthmal progenitor cells restore normal gastric lineage cells during damage recovery in adult mouse stomach
- (2017) Eunyoung Choi et al. GUT
- MicroRNA-141 suppresses prostate cancer stem cells and metastasis by targeting a cohort of pro-metastasis genes
- (2017) Can Liu et al. Nature Communications
- c-Myc Antagonises the Transcriptional Activity of the Androgen Receptor in Prostate Cancer Affecting Key Gene Networks
- (2017) Stefan J. Barfeld et al. EBioMedicine
- ErbB2 Signaling Increases Androgen Receptor Expression in Abiraterone-Resistant Prostate Cancer
- (2016) S. Gao et al. CLINICAL CANCER RESEARCH
- Defining a Population of Stem-like Human Prostate Cancer Cells That Can Generate and Propagate Castration-Resistant Prostate Cancer
- (2016) X. Chen et al. CLINICAL CANCER RESEARCH
- Lrig1 is a cell‐intrinsic modulator of hippocampal dendrite complexity and BDNF signaling
- (2016) Fernando Cruz Alsina et al. EMBO REPORTS
- Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancer
- (2016) Dingxiao Zhang et al. Nature Communications
- Compartmentalized Epidermal Activation of β-Catenin Differentially Affects Lineage Reprogramming and Underlies Tumor Heterogeneity
- (2016) Kai Kretzschmar et al. Cell Reports
- NANOG reprograms prostate cancer cells to castration resistance via dynamically repressing and engaging the AR/FOXA1 signaling axis
- (2016) Collene R Jeter et al. Cell Discovery
- LRIG1 is a prognostic biomarker in non-small cell lung cancer
- (2015) Samuel Kvarnbrink et al. ACTA ONCOLOGICA
- Loss of Lrig1 Leads to Expansion of Brunner Glands Followed by Duodenal Adenomas with Gastric Metaplasia
- (2015) Yang Wang et al. AMERICAN JOURNAL OF PATHOLOGY
- Dynamic Expansion of Gastric Mucosal Doublecortin-Like Kinase 1–Expressing Cells in Response to Parietal Cell Loss Is Regulated by Gastrin
- (2015) Eunyoung Choi et al. AMERICAN JOURNAL OF PATHOLOGY
- LRIG1, a 3p tumor suppressor, represses EGFR signaling and is a novel epigenetic silenced gene in colorectal cancer
- (2015) Changhua Kou et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- LRIG1 Regulates Ontogeny of Smooth Muscle−Derived Subsets of Interstitial Cells of Cajal in Mice
- (2015) Jumpei Kondo et al. GASTROENTEROLOGY
- Decreased LRIG1 in fulvestrant-treated luminal breast cancer cells permits ErbB3 upregulation and increased growth
- (2015) M M Morrison et al. ONCOGENE
- LRIG1 opposes epithelial-to-mesenchymal transition and inhibits invasion of basal-like breast cancer cells
- (2015) N Yokdang et al. ONCOGENE
- LRIG and cancer prognosis
- (2014) David Lindquist et al. ACTA ONCOLOGICA
- Inducible loss of one Apc allele in Lrig1-expressing progenitor cells results in multiple distal colonic tumors with features of familial adenomatous polyposis
- (2014) Anne E. Powell et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Expression of LRIG1 is associated with good prognosis and human papillomavirus status in oropharyngeal cancer
- (2014) D Lindquist et al. BRITISH JOURNAL OF CANCER
- Loss of LRIG1 Locus Increases Risk of Early and Late Relapse of Stage I/II Breast Cancer
- (2014) P. A. Thompson et al. CANCER RESEARCH
- The LRIG family: enigmatic regulators of growth factor receptor signaling
- (2014) Catalina Simion et al. ENDOCRINE-RELATED CANCER
- Androgen receptor and its splice variant, AR-V7, differentially regulate FOXA1 sensitive genes in LNCaP prostate cancer cells
- (2014) William C. Krause et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Conversion of Androgen Receptor Signaling From a Growth Suppressor in Normal Prostate Epithelial Cells to an Oncogene in Prostate Cancer Cells Involves a Gain of Function in c-Myc Regulation
- (2014) Donald J. Vander Griend et al. International Journal of Biological Sciences
- A pan-cancer proteomic perspective on The Cancer Genome Atlas
- (2014) Rehan Akbani et al. Nature Communications
- LRIG1 is a triple threat: ERBB negative regulator, intestinal stem cell marker and tumour suppressor
- (2013) Y Wang et al. BRITISH JOURNAL OF CANCER
- The Epidermis Comprises Autonomous Compartments Maintained by Distinct Stem Cell Populations
- (2013) Mahalia E. Page et al. Cell Stem Cell
- Next-generation Sequencing of Advanced Prostate Cancer Treated with Androgen-deprivation Therapy
- (2013) Prabhakar Rajan et al. EUROPEAN UROLOGY
- LRIG1 inhibits STAT3-dependent inflammation to maintain corneal homeostasis
- (2013) Takahiro Nakamura et al. JOURNAL OF CLINICAL INVESTIGATION
- Androgen Receptor Promotes Ligand-Independent Prostate Cancer Progression through c-Myc Upregulation
- (2013) Lina Gao et al. PLoS One
- The Interfollicular Epidermis of Adult Mouse Tail Comprises Two Distinct Cell Lineages that Are Differentially Regulated by Wnt, Edaradd, and Lrig1
- (2013) Céline Gomez et al. Stem Cell Reports
- LRIG1 Modulates Cancer Cell Sensitivity to Smac Mimetics by Regulating TNF Expression and Receptor Tyrosine Kinase Signaling
- (2012) L. Bai et al. CANCER RESEARCH
- The Pan-ErbB Negative Regulator Lrig1 Is an Intestinal Stem Cell Marker that Functions as a Tumor Suppressor
- (2012) Anne E. Powell et al. CELL
- The PSA−/lo Prostate Cancer Cell Population Harbors Self-Renewing Long-Term Tumor-Propagating Cells that Resist Castration
- (2012) Jichao Qin et al. Cell Stem Cell
- Lrig1 controls intestinal stem-cell homeostasis by negative regulation of ErbB signalling
- (2012) Vivian W. Y. Wong et al. NATURE CELL BIOLOGY
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Regulation of epidermal growth factor receptor signalling by inducible feedback inhibitors
- (2011) O. Segatto et al. JOURNAL OF CELL SCIENCE
- Lrig1 Is an Estrogen-Regulated Growth Suppressor and Correlates with Longer Relapse-Free Survival in ER -Positive Breast Cancer
- (2011) S. R. Krig et al. MOLECULAR CANCER RESEARCH
- The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44
- (2011) Can Liu et al. NATURE MEDICINE
- p16Ink4a overexpression in cancer: a tumor suppressor gene associated with senescence and high-grade tumors
- (2011) C Romagosa et al. ONCOGENE
- Stemness markers characterize IGR-CaP1, a new cell line derived from primary epithelial prostate cancer
- (2010) Anne Chauchereau et al. EXPERIMENTAL CELL RESEARCH
- Molecular genetics of prostate cancer: new prospects for old challenges
- (2010) M. M. Shen et al. GENES & DEVELOPMENT
- LRIG1 and the liar paradox in prostate cancer: A study of the expression and clinical significance of LRIG1 in prostate cancer
- (2010) Marcus Thomasson et al. INTERNATIONAL JOURNAL OF CANCER
- Transgenic expression of 15-lipoxygenase 2 (15-LOX2) in mouse prostate leads to hyperplasia and cell senescence
- (2010) M V Suraneni et al. ONCOGENE
- MYC Overexpression Induces Prostatic Intraepithelial Neoplasia and Loss of Nkx3.1 in Mouse Luminal Epithelial Cells
- (2010) Tsuyoshi Iwata et al. PLoS One
- Androgen Receptor Controls EGFR and ERBB2 Gene Expression at Different Levels in Prostate Cancer Cell Lines
- (2009) J.-C. Pignon et al. CANCER RESEARCH
- Androgen Receptor Regulates a Distinct Transcription Program in Androgen-Independent Prostate Cancer
- (2009) Qianben Wang et al. CELL
- Lrig1 Expression Defines a Distinct Multipotent Stem Cell Population in Mammalian Epidermis
- (2009) Kim B. Jensen et al. Cell Stem Cell
- Upregulation of LRIG1 suppresses malignant glioma cell growth by attenuating EGFR activity
- (2009) Fei Ye et al. JOURNAL OF NEURO-ONCOLOGY
- Interactions between Cells with Distinct Mutations in c-MYC and Pten in Prostate Cancer
- (2009) Jongchan Kim et al. PLoS Genetics
- Suppression of the Negative Regulator LRIG1 Contributes to ErbB2 Overexpression in Breast Cancer
- (2008) J. K. Miller et al. CANCER RESEARCH
- Lrig1 Is an Endogenous Inhibitor of Ret Receptor Tyrosine Kinase Activation, Downstream Signaling, and Biological Responses to GDNF
- (2008) F. Ledda et al. JOURNAL OF NEUROSCIENCE
- Nuclear MYC protein overexpression is an early alteration in human prostate carcinogenesis
- (2008) Bora Gurel et al. MODERN PATHOLOGY
- LRIG1 negatively regulates the oncogenic EGF receptor mutant EGFRvIII
- (2008) M A Stutz et al. ONCOGENE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now